Canada Pension Plan Investment Board’s Seaport Therapeutics SPTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SPTX Stock Details SPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.9M	Buy	+1,975,791	New	+$34.8M	0.02%	417

Other funds holding SPTX

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TGV

TRV GP VI Boston, Massachusetts $232M AUM 247.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Canada Pension Plan Investment Board's SPTX Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Seaport Therapeutics (SPTX) in Q2 2026: 1,975,791 shares worth $42.9M. The stake represents 0.02% of the portfolio and ranks #417 among its holdings.

47 funds tracked by Wall St. Rank hold SPTX as of Q2 2026.

Canada Pension Plan Investment Board held 1,975,791 shares of Seaport Therapeutics worth $42.9M as of Q2 2026.
Seaport Therapeutics was a new Canada Pension Plan Investment Board position in Q2 2026.
Seaport Therapeutics made up 0.02% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #417 holding.
47 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.